nodes	percent_of_prediction	percent_of_DWPC	metapath
Desonide—NR3C1—epilepsy syndrome	0.751	1	CbGaD
Desonide—Rash—Amobarbital—epilepsy syndrome	0.000614	0.00257	CcSEcCtD
Desonide—Pharyngitis—Phenytoin—epilepsy syndrome	0.000614	0.00257	CcSEcCtD
Desonide—Dermatitis—Amobarbital—epilepsy syndrome	0.000613	0.00257	CcSEcCtD
Desonide—Oedema peripheral—Clonazepam—epilepsy syndrome	0.000613	0.00257	CcSEcCtD
Desonide—Pharyngitis—Oxcarbazepine—epilepsy syndrome	0.00061	0.00256	CcSEcCtD
Desonide—Headache—Amobarbital—epilepsy syndrome	0.00061	0.00255	CcSEcCtD
Desonide—Sweating—Lamotrigine—epilepsy syndrome	0.000609	0.00255	CcSEcCtD
Desonide—Mental disorder—Vigabatrin—epilepsy syndrome	0.000607	0.00254	CcSEcCtD
Desonide—Oedema peripheral—Oxcarbazepine—epilepsy syndrome	0.000606	0.00254	CcSEcCtD
Desonide—Mental disorder—Diazepam—epilepsy syndrome	0.000597	0.0025	CcSEcCtD
Desonide—Erythema—Diazepam—epilepsy syndrome	0.000594	0.00248	CcSEcCtD
Desonide—Rash—Primidone—epilepsy syndrome	0.000592	0.00248	CcSEcCtD
Desonide—Dermatitis—Primidone—epilepsy syndrome	0.000591	0.00247	CcSEcCtD
Desonide—Headache—Primidone—epilepsy syndrome	0.000588	0.00246	CcSEcCtD
Desonide—Pharyngitis—Carbamazepine—epilepsy syndrome	0.000586	0.00245	CcSEcCtD
Desonide—Pruritus—Trimethadione—epilepsy syndrome	0.000584	0.00244	CcSEcCtD
Desonide—Mediastinal disorder—Zonisamide—epilepsy syndrome	0.000582	0.00244	CcSEcCtD
Desonide—Oedema peripheral—Carbamazepine—epilepsy syndrome	0.000581	0.00243	CcSEcCtD
Desonide—Cough—Propofol—epilepsy syndrome	0.000579	0.00242	CcSEcCtD
Desonide—Cough—Midazolam—epilepsy syndrome	0.000566	0.00237	CcSEcCtD
Desonide—Pharyngitis—Lamotrigine—epilepsy syndrome	0.000566	0.00237	CcSEcCtD
Desonide—Mental disorder—Zonisamide—epilepsy syndrome	0.000566	0.00237	CcSEcCtD
Desonide—Irritability—Pregabalin—epilepsy syndrome	0.000565	0.00237	CcSEcCtD
Desonide—Oedema peripheral—Lamotrigine—epilepsy syndrome	0.000562	0.00235	CcSEcCtD
Desonide—Cough—Levetiracetam—epilepsy syndrome	0.000559	0.00234	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Midazolam—epilepsy syndrome	0.000549	0.0023	CcSEcCtD
Desonide—Mental disorder—Clonazepam—epilepsy syndrome	0.000545	0.00228	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Levetiracetam—epilepsy syndrome	0.000542	0.00227	CcSEcCtD
Desonide—Cough—Fosphenytoin—epilepsy syndrome	0.00054	0.00226	CcSEcCtD
Desonide—Mental disorder—Oxcarbazepine—epilepsy syndrome	0.000539	0.00226	CcSEcCtD
Desonide—Mediastinal disorder—Carbamazepine—epilepsy syndrome	0.000532	0.00223	CcSEcCtD
Desonide—Cough—Vigabatrin—epilepsy syndrome	0.000526	0.0022	CcSEcCtD
Desonide—Hyperhidrosis—Propofol—epilepsy syndrome	0.000523	0.00219	CcSEcCtD
Desonide—Rash—Trimethadione—epilepsy syndrome	0.00052	0.00218	CcSEcCtD
Desonide—Dermatitis—Trimethadione—epilepsy syndrome	0.00052	0.00218	CcSEcCtD
Desonide—Infection—Levetiracetam—epilepsy syndrome	0.00052	0.00218	CcSEcCtD
Desonide—Nervous system disorder—Midazolam—epilepsy syndrome	0.000519	0.00217	CcSEcCtD
Desonide—Irritability—Gabapentin—epilepsy syndrome	0.000518	0.00217	CcSEcCtD
Desonide—Cough—Diazepam—epilepsy syndrome	0.000518	0.00217	CcSEcCtD
Desonide—Mental disorder—Carbamazepine—epilepsy syndrome	0.000517	0.00216	CcSEcCtD
Desonide—Headache—Trimethadione—epilepsy syndrome	0.000517	0.00216	CcSEcCtD
Desonide—Skin disorder—Midazolam—epilepsy syndrome	0.000514	0.00215	CcSEcCtD
Desonide—Mediastinal disorder—Lamotrigine—epilepsy syndrome	0.000514	0.00215	CcSEcCtD
Desonide—Erythema—Carbamazepine—epilepsy syndrome	0.000514	0.00215	CcSEcCtD
Desonide—Nervous system disorder—Levetiracetam—epilepsy syndrome	0.000513	0.00215	CcSEcCtD
Desonide—Asthma—Pregabalin—epilepsy syndrome	0.000512	0.00214	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Vigabatrin—epilepsy syndrome	0.00051	0.00213	CcSEcCtD
Desonide—Skin disorder—Levetiracetam—epilepsy syndrome	0.000508	0.00213	CcSEcCtD
Desonide—Pruritus—Rufinamide—epilepsy syndrome	0.000508	0.00213	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Diazepam—epilepsy syndrome	0.000502	0.0021	CcSEcCtD
Desonide—Infection—Fosphenytoin—epilepsy syndrome	0.000501	0.0021	CcSEcCtD
Desonide—Cough—Felbamate—epilepsy syndrome	0.000501	0.0021	CcSEcCtD
Desonide—Mental disorder—Lamotrigine—epilepsy syndrome	0.0005	0.00209	CcSEcCtD
Desonide—Erythema—Lamotrigine—epilepsy syndrome	0.000497	0.00208	CcSEcCtD
Desonide—Cough—Zonisamide—epilepsy syndrome	0.000491	0.00205	CcSEcCtD
Desonide—Infection—Vigabatrin—epilepsy syndrome	0.000489	0.00205	CcSEcCtD
Desonide—Hyperhidrosis—Fosphenytoin—epilepsy syndrome	0.000488	0.00204	CcSEcCtD
Desonide—Sweating—Valproic Acid—epilepsy syndrome	0.000484	0.00203	CcSEcCtD
Desonide—Nervous system disorder—Vigabatrin—epilepsy syndrome	0.000482	0.00202	CcSEcCtD
Desonide—Infection—Diazepam—epilepsy syndrome	0.000481	0.00201	CcSEcCtD
Desonide—Skin disorder—Vigabatrin—epilepsy syndrome	0.000478	0.002	CcSEcCtD
Desonide—Pruritus—Lacosamide—epilepsy syndrome	0.000477	0.002	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Zonisamide—epilepsy syndrome	0.000475	0.00199	CcSEcCtD
Desonide—Nervous system disorder—Diazepam—epilepsy syndrome	0.000475	0.00199	CcSEcCtD
Desonide—Cough—Clonazepam—epilepsy syndrome	0.000473	0.00198	CcSEcCtD
Desonide—Skin disorder—Diazepam—epilepsy syndrome	0.00047	0.00197	CcSEcCtD
Desonide—Cough—Phenytoin—epilepsy syndrome	0.00047	0.00197	CcSEcCtD
Desonide—Asthma—Gabapentin—epilepsy syndrome	0.000469	0.00197	CcSEcCtD
Desonide—Hyperhidrosis—Diazepam—epilepsy syndrome	0.000468	0.00196	CcSEcCtD
Desonide—Cough—Oxcarbazepine—epilepsy syndrome	0.000467	0.00196	CcSEcCtD
Desonide—Infection—Felbamate—epilepsy syndrome	0.000466	0.00195	CcSEcCtD
Desonide—Pain—Propofol—epilepsy syndrome	0.000463	0.00194	CcSEcCtD
Desonide—Pruritus—Clobazam—epilepsy syndrome	0.000463	0.00194	CcSEcCtD
Desonide—Hyperglycaemia—Pregabalin—epilepsy syndrome	0.000462	0.00193	CcSEcCtD
Desonide—Rash—Phenobarbital—epilepsy syndrome	0.000461	0.00193	CcSEcCtD
Desonide—Dermatitis—Phenobarbital—epilepsy syndrome	0.00046	0.00193	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Clonazepam—epilepsy syndrome	0.000458	0.00192	CcSEcCtD
Desonide—Headache—Phenobarbital—epilepsy syndrome	0.000458	0.00192	CcSEcCtD
Desonide—Infestation NOS—Pregabalin—epilepsy syndrome	0.000456	0.00191	CcSEcCtD
Desonide—Infestation—Pregabalin—epilepsy syndrome	0.000456	0.00191	CcSEcCtD
Desonide—Infection—Zonisamide—epilepsy syndrome	0.000456	0.00191	CcSEcCtD
Desonide—Hyperhidrosis—Felbamate—epilepsy syndrome	0.000453	0.0019	CcSEcCtD
Desonide—Pain—Midazolam—epilepsy syndrome	0.000453	0.0019	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Oxcarbazepine—epilepsy syndrome	0.000453	0.0019	CcSEcCtD
Desonide—Rash—Rufinamide—epilepsy syndrome	0.000452	0.00189	CcSEcCtD
Desonide—Dermatitis—Rufinamide—epilepsy syndrome	0.000452	0.00189	CcSEcCtD
Desonide—Nervous system disorder—Zonisamide—epilepsy syndrome	0.00045	0.00188	CcSEcCtD
Desonide—Pharyngitis—Valproic Acid—epilepsy syndrome	0.00045	0.00188	CcSEcCtD
Desonide—Headache—Rufinamide—epilepsy syndrome	0.000449	0.00188	CcSEcCtD
Desonide—Pain—Levetiracetam—epilepsy syndrome	0.000447	0.00187	CcSEcCtD
Desonide—Oedema peripheral—Valproic Acid—epilepsy syndrome	0.000447	0.00187	CcSEcCtD
Desonide—Skin disorder—Zonisamide—epilepsy syndrome	0.000446	0.00187	CcSEcCtD
Desonide—Hyperhidrosis—Zonisamide—epilepsy syndrome	0.000444	0.00186	CcSEcCtD
Desonide—Infection—Clonazepam—epilepsy syndrome	0.000439	0.00184	CcSEcCtD
Desonide—Sweating—Pregabalin—epilepsy syndrome	0.000438	0.00183	CcSEcCtD
Desonide—Infection—Phenytoin—epilepsy syndrome	0.000436	0.00183	CcSEcCtD
Desonide—Upper respiratory tract infection—Gabapentin—epilepsy syndrome	0.000436	0.00183	CcSEcCtD
Desonide—Irritability—Topiramate—epilepsy syndrome	0.000436	0.00183	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Carbamazepine—epilepsy syndrome	0.000434	0.00182	CcSEcCtD
Desonide—Infection—Oxcarbazepine—epilepsy syndrome	0.000434	0.00182	CcSEcCtD
Desonide—Nervous system disorder—Clonazepam—epilepsy syndrome	0.000434	0.00182	CcSEcCtD
Desonide—Cough—Lamotrigine—epilepsy syndrome	0.000433	0.00181	CcSEcCtD
Desonide—Nervous system disorder—Phenytoin—epilepsy syndrome	0.000431	0.0018	CcSEcCtD
Desonide—Skin disorder—Clonazepam—epilepsy syndrome	0.00043	0.0018	CcSEcCtD
Desonide—Nervous system disorder—Oxcarbazepine—epilepsy syndrome	0.000429	0.00179	CcSEcCtD
Desonide—Rash—Lacosamide—epilepsy syndrome	0.000425	0.00178	CcSEcCtD
Desonide—Hyperhidrosis—Phenytoin—epilepsy syndrome	0.000425	0.00178	CcSEcCtD
Desonide—Skin disorder—Oxcarbazepine—epilepsy syndrome	0.000424	0.00178	CcSEcCtD
Desonide—Dermatitis—Lacosamide—epilepsy syndrome	0.000424	0.00178	CcSEcCtD
Desonide—Hyperglycaemia—Gabapentin—epilepsy syndrome	0.000423	0.00177	CcSEcCtD
Desonide—Hyperhidrosis—Oxcarbazepine—epilepsy syndrome	0.000422	0.00177	CcSEcCtD
Desonide—Headache—Lacosamide—epilepsy syndrome	0.000422	0.00177	CcSEcCtD
Desonide—Pain—Vigabatrin—epilepsy syndrome	0.000421	0.00176	CcSEcCtD
Desonide—Infestation NOS—Gabapentin—epilepsy syndrome	0.000419	0.00175	CcSEcCtD
Desonide—Infestation—Gabapentin—epilepsy syndrome	0.000419	0.00175	CcSEcCtD
Desonide—Infection—Carbamazepine—epilepsy syndrome	0.000417	0.00174	CcSEcCtD
Desonide—Pain—Diazepam—epilepsy syndrome	0.000414	0.00173	CcSEcCtD
Desonide—Rash—Clobazam—epilepsy syndrome	0.000412	0.00173	CcSEcCtD
Desonide—Dermatitis—Clobazam—epilepsy syndrome	0.000412	0.00172	CcSEcCtD
Desonide—Nervous system disorder—Carbamazepine—epilepsy syndrome	0.000411	0.00172	CcSEcCtD
Desonide—Headache—Clobazam—epilepsy syndrome	0.00041	0.00171	CcSEcCtD
Desonide—Mediastinal disorder—Valproic Acid—epilepsy syndrome	0.000409	0.00171	CcSEcCtD
Desonide—Skin disorder—Carbamazepine—epilepsy syndrome	0.000407	0.00171	CcSEcCtD
Desonide—Pharyngitis—Pregabalin—epilepsy syndrome	0.000407	0.0017	CcSEcCtD
Desonide—Hyperhidrosis—Carbamazepine—epilepsy syndrome	0.000405	0.0017	CcSEcCtD
Desonide—Oedema peripheral—Pregabalin—epilepsy syndrome	0.000404	0.00169	CcSEcCtD
Desonide—Infection—Lamotrigine—epilepsy syndrome	0.000403	0.00169	CcSEcCtD
Desonide—Sweating—Gabapentin—epilepsy syndrome	0.000401	0.00168	CcSEcCtD
Desonide—Pain—Felbamate—epilepsy syndrome	0.000401	0.00168	CcSEcCtD
Desonide—Nervous system disorder—Lamotrigine—epilepsy syndrome	0.000397	0.00166	CcSEcCtD
Desonide—Mental disorder—Valproic Acid—epilepsy syndrome	0.000397	0.00166	CcSEcCtD
Desonide—Asthma—Topiramate—epilepsy syndrome	0.000395	0.00165	CcSEcCtD
Desonide—Hyperhidrosis—Lamotrigine—epilepsy syndrome	0.000392	0.00164	CcSEcCtD
Desonide—Prednisone—SLCO1A2—epilepsy syndrome	0.000388	0.0433	CrCbGaD
Desonide—Pruritus—Propofol—epilepsy syndrome	0.000383	0.0016	CcSEcCtD
Desonide—Pain—Clonazepam—epilepsy syndrome	0.000378	0.00158	CcSEcCtD
Desonide—Pruritus—Midazolam—epilepsy syndrome	0.000375	0.00157	CcSEcCtD
Desonide—Pain—Oxcarbazepine—epilepsy syndrome	0.000374	0.00156	CcSEcCtD
Desonide—Pharyngitis—Gabapentin—epilepsy syndrome	0.000373	0.00156	CcSEcCtD
Desonide—Oedema peripheral—Gabapentin—epilepsy syndrome	0.00037	0.00155	CcSEcCtD
Desonide—Pruritus—Levetiracetam—epilepsy syndrome	0.00037	0.00155	CcSEcCtD
Desonide—Mediastinal disorder—Pregabalin—epilepsy syndrome	0.000369	0.00155	CcSEcCtD
Desonide—Upper respiratory tract infection—Topiramate—epilepsy syndrome	0.000367	0.00154	CcSEcCtD
Desonide—Headache—Acetazolamide—epilepsy syndrome	0.000365	0.00153	CcSEcCtD
Desonide—Mental disorder—Pregabalin—epilepsy syndrome	0.000359	0.0015	CcSEcCtD
Desonide—Pain—Carbamazepine—epilepsy syndrome	0.000359	0.0015	CcSEcCtD
Desonide—Prednisolone—SLCO1A2—epilepsy syndrome	0.000358	0.0399	CrCbGaD
Desonide—Pruritus—Fosphenytoin—epilepsy syndrome	0.000357	0.00149	CcSEcCtD
Desonide—Hyperglycaemia—Topiramate—epilepsy syndrome	0.000356	0.00149	CcSEcCtD
Desonide—Infestation NOS—Topiramate—epilepsy syndrome	0.000352	0.00147	CcSEcCtD
Desonide—Infestation—Topiramate—epilepsy syndrome	0.000352	0.00147	CcSEcCtD
Desonide—Pruritus—Vigabatrin—epilepsy syndrome	0.000348	0.00146	CcSEcCtD
Desonide—Pain—Lamotrigine—epilepsy syndrome	0.000347	0.00145	CcSEcCtD
Desonide—Cough—Valproic Acid—epilepsy syndrome	0.000344	0.00144	CcSEcCtD
Desonide—Pruritus—Diazepam—epilepsy syndrome	0.000343	0.00143	CcSEcCtD
Desonide—Rash—Propofol—epilepsy syndrome	0.000341	0.00143	CcSEcCtD
Desonide—Dermatitis—Propofol—epilepsy syndrome	0.000341	0.00143	CcSEcCtD
Desonide—Headache—Propofol—epilepsy syndrome	0.000339	0.00142	CcSEcCtD
Desonide—Mediastinal disorder—Gabapentin—epilepsy syndrome	0.000339	0.00142	CcSEcCtD
Desonide—Rash—Midazolam—epilepsy syndrome	0.000334	0.0014	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	0.000334	0.0014	CcSEcCtD
Desonide—Dermatitis—Midazolam—epilepsy syndrome	0.000334	0.0014	CcSEcCtD
Desonide—Headache—Midazolam—epilepsy syndrome	0.000332	0.00139	CcSEcCtD
Desonide—Pruritus—Felbamate—epilepsy syndrome	0.000332	0.00139	CcSEcCtD
Desonide—Rash—Levetiracetam—epilepsy syndrome	0.00033	0.00138	CcSEcCtD
Desonide—Dermatitis—Levetiracetam—epilepsy syndrome	0.000329	0.00138	CcSEcCtD
Desonide—Mental disorder—Gabapentin—epilepsy syndrome	0.000329	0.00138	CcSEcCtD
Desonide—Headache—Levetiracetam—epilepsy syndrome	0.000328	0.00137	CcSEcCtD
Desonide—Erythema—Gabapentin—epilepsy syndrome	0.000327	0.00137	CcSEcCtD
Desonide—Prednicarbate—NR3C1—epilepsy syndrome	0.000326	0.0363	CrCbGaD
Desonide—Clocortolone—NR3C1—epilepsy syndrome	0.000326	0.0363	CrCbGaD
Desonide—Pruritus—Zonisamide—epilepsy syndrome	0.000325	0.00136	CcSEcCtD
Desonide—Infection—Valproic Acid—epilepsy syndrome	0.00032	0.00134	CcSEcCtD
Desonide—Rash—Fosphenytoin—epilepsy syndrome	0.000318	0.00133	CcSEcCtD
Desonide—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000318	0.00133	CcSEcCtD
Desonide—Headache—Fosphenytoin—epilepsy syndrome	0.000316	0.00132	CcSEcCtD
Desonide—Nervous system disorder—Valproic Acid—epilepsy syndrome	0.000316	0.00132	CcSEcCtD
Desonide—Pharyngitis—Topiramate—epilepsy syndrome	0.000314	0.00131	CcSEcCtD
Desonide—Pruritus—Clonazepam—epilepsy syndrome	0.000313	0.00131	CcSEcCtD
Desonide—Skin disorder—Valproic Acid—epilepsy syndrome	0.000313	0.00131	CcSEcCtD
Desonide—Oedema peripheral—Topiramate—epilepsy syndrome	0.000311	0.0013	CcSEcCtD
Desonide—Hyperhidrosis—Valproic Acid—epilepsy syndrome	0.000311	0.0013	CcSEcCtD
Desonide—Cough—Pregabalin—epilepsy syndrome	0.000311	0.0013	CcSEcCtD
Desonide—Pruritus—Phenytoin—epilepsy syndrome	0.000311	0.0013	CcSEcCtD
Desonide—Rash—Vigabatrin—epilepsy syndrome	0.00031	0.0013	CcSEcCtD
Desonide—Dermatitis—Vigabatrin—epilepsy syndrome	0.00031	0.0013	CcSEcCtD
Desonide—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000309	0.00129	CcSEcCtD
Desonide—Diflorasone—NR3C1—epilepsy syndrome	0.000308	0.0344	CrCbGaD
Desonide—Headache—Vigabatrin—epilepsy syndrome	0.000308	0.00129	CcSEcCtD
Desonide—Rash—Diazepam—epilepsy syndrome	0.000305	0.00128	CcSEcCtD
Desonide—Dermatitis—Diazepam—epilepsy syndrome	0.000305	0.00128	CcSEcCtD
Desonide—Headache—Diazepam—epilepsy syndrome	0.000303	0.00127	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	0.000302	0.00126	CcSEcCtD
Desonide—Desoximetasone—NR3C1—epilepsy syndrome	0.000301	0.0335	CrCbGaD
Desonide—Loteprednol—NR3C1—epilepsy syndrome	0.000297	0.0331	CrCbGaD
Desonide—Pruritus—Carbamazepine—epilepsy syndrome	0.000297	0.00124	CcSEcCtD
Desonide—Rash—Felbamate—epilepsy syndrome	0.000296	0.00124	CcSEcCtD
Desonide—Dermatitis—Felbamate—epilepsy syndrome	0.000295	0.00124	CcSEcCtD
Desonide—Headache—Felbamate—epilepsy syndrome	0.000294	0.00123	CcSEcCtD
Desonide—Rash—Zonisamide—epilepsy syndrome	0.000289	0.00121	CcSEcCtD
Desonide—Infection—Pregabalin—epilepsy syndrome	0.000289	0.00121	CcSEcCtD
Desonide—Dermatitis—Zonisamide—epilepsy syndrome	0.000289	0.00121	CcSEcCtD
Desonide—Headache—Zonisamide—epilepsy syndrome	0.000287	0.0012	CcSEcCtD
Desonide—Pruritus—Lamotrigine—epilepsy syndrome	0.000287	0.0012	CcSEcCtD
Desonide—Nervous system disorder—Pregabalin—epilepsy syndrome	0.000286	0.0012	CcSEcCtD
Desonide—Cough—Gabapentin—epilepsy syndrome	0.000285	0.00119	CcSEcCtD
Desonide—Mediastinal disorder—Topiramate—epilepsy syndrome	0.000285	0.00119	CcSEcCtD
Desonide—Skin disorder—Pregabalin—epilepsy syndrome	0.000283	0.00118	CcSEcCtD
Desonide—Hyperhidrosis—Pregabalin—epilepsy syndrome	0.000281	0.00118	CcSEcCtD
Desonide—Rash—Clonazepam—epilepsy syndrome	0.000279	0.00117	CcSEcCtD
Desonide—Dermatitis—Clonazepam—epilepsy syndrome	0.000279	0.00117	CcSEcCtD
Desonide—Headache—Clonazepam—epilepsy syndrome	0.000277	0.00116	CcSEcCtD
Desonide—Rash—Phenytoin—epilepsy syndrome	0.000277	0.00116	CcSEcCtD
Desonide—Mental disorder—Topiramate—epilepsy syndrome	0.000277	0.00116	CcSEcCtD
Desonide—Dermatitis—Phenytoin—epilepsy syndrome	0.000277	0.00116	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	0.000277	0.00116	CcSEcCtD
Desonide—Rash—Oxcarbazepine—epilepsy syndrome	0.000276	0.00115	CcSEcCtD
Desonide—Pain—Valproic Acid—epilepsy syndrome	0.000275	0.00115	CcSEcCtD
Desonide—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000275	0.00115	CcSEcCtD
Desonide—Headache—Phenytoin—epilepsy syndrome	0.000275	0.00115	CcSEcCtD
Desonide—Erythema—Topiramate—epilepsy syndrome	0.000275	0.00115	CcSEcCtD
Desonide—Hydrocortisone—SLCO1A2—epilepsy syndrome	0.000274	0.0305	CrCbGaD
Desonide—Headache—Oxcarbazepine—epilepsy syndrome	0.000274	0.00115	CcSEcCtD
Desonide—Infection—Gabapentin—epilepsy syndrome	0.000265	0.00111	CcSEcCtD
Desonide—Rash—Carbamazepine—epilepsy syndrome	0.000264	0.00111	CcSEcCtD
Desonide—Dermatitis—Carbamazepine—epilepsy syndrome	0.000264	0.00111	CcSEcCtD
Desonide—Flurandrenolide—NR3C1—epilepsy syndrome	0.000263	0.0293	CrCbGaD
Desonide—Headache—Carbamazepine—epilepsy syndrome	0.000263	0.0011	CcSEcCtD
Desonide—Nervous system disorder—Gabapentin—epilepsy syndrome	0.000262	0.0011	CcSEcCtD
Desonide—Skin disorder—Gabapentin—epilepsy syndrome	0.000259	0.00109	CcSEcCtD
Desonide—Hyperhidrosis—Gabapentin—epilepsy syndrome	0.000258	0.00108	CcSEcCtD
Desonide—Rash—Lamotrigine—epilepsy syndrome	0.000256	0.00107	CcSEcCtD
Desonide—Dermatitis—Lamotrigine—epilepsy syndrome	0.000255	0.00107	CcSEcCtD
Desonide—Hydrocortamate—NR3C1—epilepsy syndrome	0.000255	0.0284	CrCbGaD
Desonide—Headache—Lamotrigine—epilepsy syndrome	0.000254	0.00106	CcSEcCtD
Desonide—Pain—Pregabalin—epilepsy syndrome	0.000249	0.00104	CcSEcCtD
Desonide—Cough—Topiramate—epilepsy syndrome	0.00024	0.00101	CcSEcCtD
Desonide—Amcinonide—NR3C1—epilepsy syndrome	0.000237	0.0264	CrCbGaD
Desonide—Budesonide—NR3C1—epilepsy syndrome	0.000237	0.0264	CrCbGaD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	0.000233	0.000974	CcSEcCtD
Desonide—Pain—Gabapentin—epilepsy syndrome	0.000228	0.000956	CcSEcCtD
Desonide—Pruritus—Valproic Acid—epilepsy syndrome	0.000228	0.000954	CcSEcCtD
Desonide—Mometasone—NR3C1—epilepsy syndrome	0.000225	0.0251	CrCbGaD
Desonide—Infection—Topiramate—epilepsy syndrome	0.000223	0.000934	CcSEcCtD
Desonide—Rimexolone—NR3C1—epilepsy syndrome	0.000223	0.0248	CrCbGaD
Desonide—Nervous system disorder—Topiramate—epilepsy syndrome	0.00022	0.000922	CcSEcCtD
Desonide—Skin disorder—Topiramate—epilepsy syndrome	0.000218	0.000913	CcSEcCtD
Desonide—Hyperhidrosis—Topiramate—epilepsy syndrome	0.000217	0.000909	CcSEcCtD
Desonide—Beclomethasone—NR3C1—epilepsy syndrome	0.00021	0.0234	CrCbGaD
Desonide—Fluocinonide—NR3C1—epilepsy syndrome	0.00021	0.0234	CrCbGaD
Desonide—Pruritus—Pregabalin—epilepsy syndrome	0.000206	0.000862	CcSEcCtD
Desonide—Fluocinolone Acetonide—NR3C1—epilepsy syndrome	0.000204	0.0227	CrCbGaD
Desonide—Alclometasone—NR3C1—epilepsy syndrome	0.000204	0.0227	CrCbGaD
Desonide—Dexamethasone—SLCO1A2—epilepsy syndrome	0.000204	0.0227	CrCbGaD
Desonide—Rash—Valproic Acid—epilepsy syndrome	0.000203	0.00085	CcSEcCtD
Desonide—Dermatitis—Valproic Acid—epilepsy syndrome	0.000203	0.000849	CcSEcCtD
Desonide—Headache—Valproic Acid—epilepsy syndrome	0.000202	0.000845	CcSEcCtD
Desonide—Fludrocortisone—NR3C1—epilepsy syndrome	0.000199	0.0221	CrCbGaD
Desonide—Flunisolide—NR3C1—epilepsy syndrome	0.000199	0.0221	CrCbGaD
Desonide—Clobetasol propionate—NR3C1—epilepsy syndrome	0.000199	0.0221	CrCbGaD
Desonide—Paramethasone—NR3C1—epilepsy syndrome	0.000196	0.0219	CrCbGaD
Desonide—Ciclesonide—NR3C1—epilepsy syndrome	0.000193	0.0215	CrCbGaD
Desonide—Triamcinolone—BCHE—epilepsy syndrome	0.000192	0.0214	CrCbGaD
Desonide—Pain—Topiramate—epilepsy syndrome	0.000192	0.000804	CcSEcCtD
Desonide—Fluorometholone—NR3C1—epilepsy syndrome	0.000192	0.0213	CrCbGaD
Desonide—Pruritus—Gabapentin—epilepsy syndrome	0.000189	0.000791	CcSEcCtD
Desonide—Methylprednisolone—NR3C1—epilepsy syndrome	0.000185	0.0206	CrCbGaD
Desonide—Rash—Pregabalin—epilepsy syndrome	0.000184	0.000768	CcSEcCtD
Desonide—Dermatitis—Pregabalin—epilepsy syndrome	0.000183	0.000768	CcSEcCtD
Desonide—Headache—Pregabalin—epilepsy syndrome	0.000182	0.000764	CcSEcCtD
Desonide—Dexamethasone—CYP11A1—epilepsy syndrome	0.000178	0.0198	CrCbGaD
Desonide—Rash—Gabapentin—epilepsy syndrome	0.000168	0.000705	CcSEcCtD
Desonide—Dermatitis—Gabapentin—epilepsy syndrome	0.000168	0.000704	CcSEcCtD
Desonide—Headache—Gabapentin—epilepsy syndrome	0.000167	0.0007	CcSEcCtD
Desonide—Pruritus—Topiramate—epilepsy syndrome	0.000159	0.000665	CcSEcCtD
Desonide—Triamcinolone—NR3C1—epilepsy syndrome	0.000156	0.0174	CrCbGaD
Desonide—Dexamethasone—NOS2—epilepsy syndrome	0.000147	0.0164	CrCbGaD
Desonide—Prednisone—NR3C1—epilepsy syndrome	0.000142	0.0158	CrCbGaD
Desonide—Rash—Topiramate—epilepsy syndrome	0.000142	0.000593	CcSEcCtD
Desonide—Dermatitis—Topiramate—epilepsy syndrome	0.000141	0.000592	CcSEcCtD
Desonide—Headache—Topiramate—epilepsy syndrome	0.000141	0.000589	CcSEcCtD
Desonide—Prednisolone—NR3C1—epilepsy syndrome	0.000131	0.0145	CrCbGaD
Desonide—Ciclesonide—CYP2D6—epilepsy syndrome	0.00013	0.0145	CrCbGaD
Desonide—Prednisone—CYP2C19—epilepsy syndrome	0.000129	0.0144	CrCbGaD
Desonide—Betamethasone—NR3C1—epilepsy syndrome	0.000128	0.0142	CrCbGaD
Desonide—Hydrocortisone—ABCG2—epilepsy syndrome	0.000116	0.0129	CrCbGaD
Desonide—Hydrocortisone—NR3C1—epilepsy syndrome	9.98e-05	0.0111	CrCbGaD
Desonide—Dexamethasone—ABCC2—epilepsy syndrome	9.76e-05	0.0109	CrCbGaD
Desonide—Methylprednisolone—ABCB1—epilepsy syndrome	8.94e-05	0.00995	CrCbGaD
Desonide—Triamcinolone—PTGS2—epilepsy syndrome	8.86e-05	0.00987	CrCbGaD
Desonide—Dexamethasone—ABCG2—epilepsy syndrome	8.63e-05	0.00961	CrCbGaD
Desonide—Dexamethasone—NR3C1—epilepsy syndrome	7.44e-05	0.00829	CrCbGaD
Desonide—Betamethasone—PTGS2—epilepsy syndrome	7.26e-05	0.00808	CrCbGaD
Desonide—Prednisone—ALB—epilepsy syndrome	7.16e-05	0.00798	CrCbGaD
Desonide—Prednisone—ABCB1—epilepsy syndrome	6.83e-05	0.00761	CrCbGaD
Desonide—Dexamethasone—CYP2C19—epilepsy syndrome	6.78e-05	0.00755	CrCbGaD
Desonide—Prednisolone—ABCB1—epilepsy syndrome	6.3e-05	0.00702	CrCbGaD
Desonide—Betamethasone—ABCB1—epilepsy syndrome	6.17e-05	0.00687	CrCbGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—SNIP1—epilepsy syndrome	5.73e-05	0.0626	CbGpPWpGaD
Desonide—Dexamethasone—CYP2D6—epilepsy syndrome	5.03e-05	0.0056	CrCbGaD
Desonide—Hydrocortisone—ABCB1—epilepsy syndrome	4.82e-05	0.00537	CrCbGaD
Desonide—NR3C1—AP-1 transcription factor network—FOSB—epilepsy syndrome	4.46e-05	0.0487	CbGpPWpGaD
Desonide—Dexamethasone—PTGS2—epilepsy syndrome	4.22e-05	0.0047	CrCbGaD
Desonide—NR3C1—Endoderm Differentiation—DUSP5—epilepsy syndrome	3.79e-05	0.0413	CbGpPWpGaD
Desonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—HTR7—epilepsy syndrome	3.59e-05	0.0392	CbGpPWpGaD
Desonide—Dexamethasone—ABCB1—epilepsy syndrome	3.59e-05	0.004	CrCbGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—SNTA1—epilepsy syndrome	3.39e-05	0.037	CbGpPWpGaD
Desonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—KCNJ11—epilepsy syndrome	2.94e-05	0.0321	CbGpPWpGaD
Desonide—NR3C1—Endoderm Differentiation—DUSP4—epilepsy syndrome	2.53e-05	0.0276	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—DUSP1—epilepsy syndrome	2.05e-05	0.0224	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—ASCL1—epilepsy syndrome	1.95e-05	0.0213	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—MECP2—epilepsy syndrome	1.95e-05	0.0213	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—JUND—epilepsy syndrome	1.91e-05	0.0208	CbGpPWpGaD
Desonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—AVP—epilepsy syndrome	1.77e-05	0.0194	CbGpPWpGaD
Desonide—NR3C1—Nuclear Receptors—VDR—epilepsy syndrome	1.68e-05	0.0183	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK10—epilepsy syndrome	1.61e-05	0.0175	CbGpPWpGaD
Desonide—NR3C1—Signaling events mediated by HDAC Class II—MEF2C—epilepsy syndrome	1.59e-05	0.0173	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—RET—epilepsy syndrome	1.52e-05	0.0165	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—MIF—epilepsy syndrome	1.5e-05	0.0164	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—MAP2—epilepsy syndrome	1.48e-05	0.0161	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—SSTR1—epilepsy syndrome	1.35e-05	0.0147	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—GABRA1—epilepsy syndrome	1.35e-05	0.0147	CbGpPWpGaD
Desonide—NR3C1—Nuclear Receptor transcription pathway—VDR—epilepsy syndrome	1.33e-05	0.0145	CbGpPWpGaD
Desonide—NR3C1—Regulation of Androgen receptor activity—SIRT1—epilepsy syndrome	1.3e-05	0.0142	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—SSTR2—epilepsy syndrome	1.3e-05	0.0142	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—JUNB—epilepsy syndrome	1.3e-05	0.0142	CbGpPWpGaD
Desonide—NR3C1—Circadian Clock—AVP—epilepsy syndrome	1.29e-05	0.0141	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—TH—epilepsy syndrome	1.29e-05	0.014	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—CHRNA7—epilepsy syndrome	1.26e-05	0.0137	CbGpPWpGaD
Desonide—NR3C1—Circadian Clock—MEF2C—epilepsy syndrome	1.18e-05	0.0129	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—SLC1A3—epilepsy syndrome	1.07e-05	0.0117	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—AQP4—epilepsy syndrome	1.07e-05	0.0117	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—BMP4—epilepsy syndrome	1.01e-05	0.011	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—CHRM2—epilepsy syndrome	1e-05	0.011	CbGpPWpGaD
Desonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—epilepsy syndrome	9.62e-06	0.0105	CbGpPWpGaD
Desonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—epilepsy syndrome	9.35e-06	0.0102	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—epilepsy syndrome	9.16e-06	0.00999	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—CHRNB2—epilepsy syndrome	9.01e-06	0.00984	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MEF2C—epilepsy syndrome	8.67e-06	0.00946	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—AGT—epilepsy syndrome	8.41e-06	0.00918	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—PLAU—epilepsy syndrome	8.36e-06	0.00912	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—CHRNA4—epilepsy syndrome	8.18e-06	0.00893	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—SLC6A4—epilepsy syndrome	7.61e-06	0.0083	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—NTRK2—epilepsy syndrome	7.4e-06	0.00808	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—SST—epilepsy syndrome	7.4e-06	0.00808	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—IL1RN—epilepsy syndrome	7.37e-06	0.00804	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—FOS—epilepsy syndrome	7.09e-06	0.00774	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—CCL2—epilepsy syndrome	6.92e-06	0.00756	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—TH—epilepsy syndrome	6.78e-06	0.0074	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—SOCS3—epilepsy syndrome	6.72e-06	0.00733	CbGpPWpGaD
Desonide—NR3C1—Regulation of Androgen receptor activity—JUN—epilepsy syndrome	6.36e-06	0.00694	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOS—epilepsy syndrome	6.31e-06	0.00688	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—FOS—epilepsy syndrome	6.24e-06	0.00682	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—POMC—epilepsy syndrome	6.23e-06	0.0068	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—MEF2C—epilepsy syndrome	5.93e-06	0.00648	CbGpPWpGaD
Desonide—NR3C1—Regulation of Androgen receptor activity—SRC—epilepsy syndrome	5.7e-06	0.00622	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—AVP—epilepsy syndrome	5.61e-06	0.00612	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—BDNF—epilepsy syndrome	5.52e-06	0.00603	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—HES1—epilepsy syndrome	5.3e-06	0.00579	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—WARS—epilepsy syndrome	5.23e-06	0.00571	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—MEF2C—epilepsy syndrome	5.13e-06	0.0056	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—AGT—epilepsy syndrome	5.12e-06	0.00559	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—RELA—epilepsy syndrome	5.12e-06	0.00559	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—JUN—epilepsy syndrome	5.09e-06	0.00555	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—YWHAZ—epilepsy syndrome	4.96e-06	0.00541	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—MMP9—epilepsy syndrome	4.95e-06	0.0054	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—NGF—epilepsy syndrome	4.9e-06	0.00535	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—IL6ST—epilepsy syndrome	4.71e-06	0.00515	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—HTR2A—epilepsy syndrome	4.67e-06	0.00509	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—epilepsy syndrome	4.53e-06	0.00494	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—JUN—epilepsy syndrome	4.48e-06	0.00489	CbGpPWpGaD
Desonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—epilepsy syndrome	4.11e-06	0.00449	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—QARS—epilepsy syndrome	3.96e-06	0.00433	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—EIF2B5—epilepsy syndrome	3.17e-06	0.00346	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—JUNB—epilepsy syndrome	2.89e-06	0.00315	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—TFAM—epilepsy syndrome	2.87e-06	0.00313	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—IL1B—epilepsy syndrome	2.77e-06	0.00302	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—CASP3—epilepsy syndrome	2.76e-06	0.00301	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—JUN—epilepsy syndrome	2.68e-06	0.00293	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—epilepsy syndrome	2.52e-06	0.00275	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—epilepsy syndrome	2.5e-06	0.00273	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—SNRPE—epilepsy syndrome	2.47e-06	0.0027	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—epilepsy syndrome	2.34e-06	0.00256	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—TNF—epilepsy syndrome	2.32e-06	0.00253	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—VDR—epilepsy syndrome	2.29e-06	0.0025	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—TNF—epilepsy syndrome	2.01e-06	0.00219	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—EIF2S1—epilepsy syndrome	1.73e-06	0.00188	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—HSPB1—epilepsy syndrome	1.66e-06	0.00182	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—JUNB—epilepsy syndrome	1.39e-06	0.00152	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—SIRT1—epilepsy syndrome	1.12e-06	0.00122	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—VDR—epilepsy syndrome	1.1e-06	0.0012	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—H2AFX—epilepsy syndrome	1.05e-06	0.00114	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—YWHAZ—epilepsy syndrome	1.01e-06	0.0011	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—AKT1—epilepsy syndrome	3.04e-07	0.000332	CbGpPWpGaD
